- Home
- ORGO
as 07-26-2024 4:00pm EST
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | CANTON |
| Market Cap: | 371.2M | IPO Year: | N/A |
| Target Price: | $4.88 | AVG Volume (30 days): | 912.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.04 | EPS Growth: | -63.64 |
| 52 Week Low/High: | $1.96 - $4.71 | Next Earning Date: | 08-08-2024 |
| Revenue: | $435,474,000 | Revenue Growth: | -5.62% |
| Revenue Growth (this year): | 7.71% | Revenue Growth (next year): | 2.37% |
Stock Insider Trading Activity of Organogenesis Holdings Inc. (ORGO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ERANI ALBERT | ORGO | 10% Owner | Jan 9 '24 | Sell | $4.37 | 197,921 | $863,984.54 | 59,025,106 | SEC Form 4 |
| ERANI ALBERT | ORGO | 10% Owner | Jan 9 '24 | Sell | $4.28 | 17,972 | $76,875.23 | 59,007,134 | SEC Form 4 |
| ERANI ALBERT | ORGO | 10% Owner | Jan 9 '24 | Sell | $4.37 | 197,921 | $863,984.54 | 59,025,106 | SEC Form 4 |
| ERANI ALBERT | ORGO | 10% Owner | Jan 9 '24 | Sell | $4.28 | 17,972 | $76,875.23 | 59,007,134 | SEC Form 4 |
Latest Organogenesis Holdings Inc. News
ORGO Breaking Stock News: Dive into ORGO Ticker-Specific Updates for Smart Investing
Insider Monkey
7 days ago
Organogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now?
GlobeNewswire
11 days ago
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
Simply Wall St.
21 days ago
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?
PR Newswire
2 months ago
NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities
Business Wire
2 months ago
Form 8.3 - International Distribution Services plc
Business Wire
2 months ago
Form 8.3 - Darktrace plc
Reuters
2 months ago
US Supreme Court rejects Kroger challenge to Grubhub trademark win
Investor's Business Daily
2 months ago
Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect
Compare ORGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORGO Organogenesis Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.